Ab Index-Nr. 029-001-00-4

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
029-001-00-4copper chloride;
copper (I) chloride;
cuprous chloride
231-842-97758-89-6Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410
   
bis 28.02.2018
029-002-00-X
dicopper oxide;
copper (I) oxide
215-270-71317-39-1Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-002-00-X
Dikupferoxid;
Kupfer(I)-oxid
215-270-71317-39-1Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H332
H302
H318
H410
 M = 100 
029-003-00-5Naphthenic acids, copper salts;
copper naphthenate
215-657-01338-02-9Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H400
H410
GHS02
GHS07
GHS09
Wng
H226
H302
H410
   
029-004-00-0copper sulphate231-847-67758-98-7Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
   
029-005-00-6(tris(chloromethyl)phthalo-
cyaninato)copper
(II), reaction products with N-methylpiperazine and methoxyacetic acid
401-260-1Eye Irrit. 2H319GHS07
Wng
H319   
029-006-00-1tris(octadec-9-enylam-
monium) (trisulfonatophthalocyanina-
to)copper(II)
403-210-4Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
029-007-00-7(trisodium (2-((3-(6-(2-chloro-5-sulfonato)
anilino)-4-(3-carboxypyridinio)-
1,3,5-triazin-2-ylamino)-2
oxido-5-sulfonatopheny-
lazo)phenylmethylazo)-4-
sulfonatobenzoato)copper(3-)) hydroxide
404-670-989797-01-3Skin Sens. 1H317GHS07
Wng
H317  G
029-008-00-2copper(II) methanesulfonate405-400-254253-62-2Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
029-009-00-8phthalocyanine-N-[3-(diethylamino)propyl]
sulfonamide copper complex
413-650-993971-95-0Aquatic Chronic 3H412H412   
029-010-00-3reaction mass of compounds from (dode­cakis(p-tolylthio)phthalo­cyaninato)copper(II) to (hexade­cakis(p-tolylthio)phthalo­cyaninato)copper(II)407-700-9101408-30-4Skin Sens. 1H317GHS07
Wng
H317   
029-011-00-9sodium [29H,31H-phthalocyani-
nato-(2-)-N29,N30,N31,N32]-
((3-(N-methyl-N-(2-hydroxy-
ethyl)amino)propyl)amino)sul-
fonyl­sulfonato, copper complex
412-730-0150522-10-4Skin Corr. 1BH314GHS05
Dgr
H314   
029-012-00-4sodium ((N-(3-trimethylam-
moniopropyl)sulfamoyl)me-
thylsulfonatophthalocyani-
nato)copper(II)
407-340-2124719-24-0Eye Dam. 1H318GHS05
Dgr
H318   
029-013-00-Xtrisodium(2-(α-(3-(4-
chloro-6-(2-(2-(vinylsulfon-
yl)ethoxy)ethylamino)-1,3,5-
triazin-2-ylamino)-2-oxido-5-
sulfonatophenylazo)benzyli-
denehydrazino)-4-sulfonato-
benzoato)copper(II)
407-580-8130201-51-3Eye Dam. 1H318GHS05
Dgr
H318   
029-014-00-5reaction mass of: 2,2´-[[cis-
1,2-cyclohexanediylbis(nitri-
lomethylidene)]bis[phenola-
te]](2-)N,N´,O,O´-copper complex;
2,2´-[[trans-1,2-cyclohexane-
diylbis(nitrilomethylidy-
ne)]bis[phenolate]](2-)N,N´,O,O´-copper complex
419-610-7171866-24-3STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-015-00-0
Kupferthiocyanat214-183-11111-67-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410EUH032M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-016-00-6
Kupfer(II)-oxid215-269-11317-38-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 100 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-017-00-1
Dikupferchloridtrihydroxid215-572-91332-65-6Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H301
H400
H410
GHS06
GHS09
Dgr
H332
H301
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-018-00-7
Tetrakupferhexahydro-
xidsulfat; [1]
Tetrakupferhexahydro-
xidsulfathydrat; [2]
215-582-3 [1]
215-582-3 [2]
1333-22-8 [1]
12527-76-3 [2]
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-019-01-X
Kupferflocken (mit einem Überzug aus aliphatischer Säure)Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H319
H400
H410
GHS06
GHS09
Dgr
H331
H302
H319
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-020-00-8
Kupfer(II)-carbonat –
Kupfer(II)-hydroxid
(1:1)
235-113-612069-69-1Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H319
H400
H410
GHS07
GHS09
Wng
H332
H302
H319
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-021-00-3
Kupferdihydroxid;
Kupfer(II)-hydroxid
243-815-920427-59-2Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H302
H318
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-022-00-9
Kupferkalkbrühe (Bordeauxbrühe);
Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid
8011-63-0Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H332
H318
H410
 M = 10 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
029-023-00-4
Kupfersulfat-Pentahydrat231-847-67758-99-8Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H302
H318
H410
 M = 10 
030-001-00-1zinc powder – zinc dust (pyrophoric)231-175-37440-66-6Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H400
H410
GHS02
GHS09
Dgr
H260
H250
H410
  T
030-001-01-9zinc powder – zinc dust (stabilised)231-175-37440-66-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
030-003-00-2zinc chloride231-592-07646-85-7Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
 STOT SE 3;
H335: C ≥ 5 %
 
030-004-00-8dimethylzinc; [1]
diethylzinc [2]
208-884-1
[1]
209-161-3
[2]
544-97-8 [1]
557-20-0 [2]
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H260
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H260
H314
H410
EUH014  
030-005-00-3diamminediisocyanatozinc401-610-3Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H302
H318
H334
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H318
H334
H317
H400
   
030-006-00-9zinc sulphate (hydrous) (mono-, hexa- and
hepta hydrate); [1]
zinc sulphate (anhydrous) [2]
231-793-3
[1]
231-793-3
[2]
7446-19-7 [1]
7733-02-0 [2]
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
030-007-00-4bis(3,5-di-tert-butylsalicylato-O1,O2)zinc403-360-042405-40-3Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Dgr
H228
H302
H410
  T
030-008-00-Xhydroxo(2-(benzenesulfonamido)benzoato)
zinc(II)
403-750-0113036-91-2Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411
   
030-009-00-5zinc-bis(4-
(n-octyloxycarbonylamino)salicylate)
dihydrate
417-130-2Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
030-010-00-02-dodec-1-enylbutanedioic acid,
4-methyl ester zinc salt
430-740-3Aquatic Chronic 2H411GHS09H411   
030-011-00-6trizinc bis(orthophosphate)231-944-37779-90-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
030-012-00-1aluminium-magnesium-zinc-
carbonate-hydroxide
423-570-6169314-88-9Aquatic Chronic 4H413 H413   
030-013-00-7zinc oxide215-222-51314-13-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
030-015-00-8tetrazinc(2+)bis(hexa-
cyanocobalt(3+))
diacetate
440-060-9Aquatic Chronic 2H411GHS09H411   
031-001-00-4Galliumarsenid215-114-81303-00-0Repr. 1B
Carc. 1B
STOT RE 1
H360F
H350
H372 (Atmungs­system und häma­topoeti­sches System)
GHS08
Dgr
H360F
H350
H372 (Atmungs­system und häma­topoeti­sches System)
   
033-001-00-Xarsenic231-148-67440-38-2Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
   
033-002-00-5arsenic compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
 *A 1
033-003-00-0diarsenic trioxide;
arsenic trioxide
215-481-41327-53-3Carc. 1A
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H300
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H300
H314
H410
   
033-004-00-6diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide
215-116-91303-28-2Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
   
033-005-00-1arsenic acid and its salts with the exception of
those specified elsewhere in this Annex
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
  A
033-006-00-7arsine232-066-37784-42-1Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H330
H373 **
H400
H410
GHS02
GHS04
GHS06
GHS08
GHS09
Dgr
H220
H330
H373 **
H410
  U
033-007-00-2tert-butylarsine423-320-64262-43-5Pyr. Liq. 1
Acute Tox. 2 *
H250
H330
GHS02
GHS06
Dgr
H250
H330
   
034-001-00-2selenium231-957-47782-49-2Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4
H331
H301
H373 **
H413
GHS06
GHS08
Dgr
H331
H301
H373 **
H413
   
034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this AnnexAcute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H373 **
H410
  A
034-003-00-3sodium selenite233-267-910102-18-8Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2
H300
H331
H317
H411
GHS06
GHS09
Dgr
H300
H331
H317
H411
EUH031  
035-001-00-5bromine231-778-17726-95-6Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H330
H314
H400
GHS06
GHS05
GHS09
Dgr
H330
H314
H400
   
035-002-00-0hydrogen bromide233-113-010035-10-6Press. Gas
Skin Corr. 1A
STOT SE 3
H314
H335
GHS04
GHS05
GHS07
Dgr
H314
H335
  U
035-002-01-8hydrobromic acid ... %Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
 Skin Corr. 1B;
H314: C ≥ 40 %
Skin Irrit. 2;
H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319:
10 % ≤ C < 40 %
STOT SE 3;
H335: C ≥ 10 %
B
035-003-00-6potassium bromate231-829-87758-01-2Ox. Sol. 1
Carc. 1B
Acute Tox. 3 *
H271
H350
H301
GHS03
GHS06
GHS08
Dgr
H271
H350
H301
   
035-004-00-12-hydroxyethylammonium perbromide407-440-6Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H272
H302
H314
H317
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H317
H400
   
040-001-00-3zirconium powder (pyrophoric)231-176-97440-67-7Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250
  T
040-002-00-9zirconium powder, dry (non pyrophoric)Self-heat. 1H251GHS02
Dgr
H251  T
040-003-00-4reaction product of 3,5-di-tert-
butylsalicylic acid and zirconium
oxychloride, dehydrated, basic Zr:
DTBS = 1,0: 1,0 to 1,0: 1,5
430-610-6226996-19-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
042-001-00-9molybdenum trioxide215-204-71313-27-5Carc. 2
Eye Irrit. 2
STOT SE 3
H351
H319
H335
GHS08
GHS07
Wng
H351
H319
H335
   
042-002-00-4tetrakis(dimethylditetra­decylammonium)
hexa-μ-oxotetra-μ3-oxo­di-μ5-oxotetradecaoxooc­tamolybdate(4-)
404-760-8117342-25-3Acute Tox. 3 *
Eye Dam. 1
H331
H318
GHS06
GHS05
Dgr
H331
H318
   
042-003-00-Xtetrakis(trimethylhexadecylam­monium)
hexa-mu-oxotetra-mu3-oxodi-
mu5-oxotet-radecaoxoocta­molybdate(4-)
404-860-1116810-46-9Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H228
H318
H400
H410
GHS02
GHS05
GHS09
Dgr
H228
H318
H410
  T
042-004-00-5Reaction product of ammonium molybdate
and C12-C24-diethoxylated alkylamine (1:5-1:3)
412-780-3Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
   
042-005-00-0reaction mass of: mono- and
di-glycerols of canola oil;
canola oil acid amide of branched
1,3-propanediamine,N-
[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate
molybdenum complex
434-240-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
046-001-00-Xtetraammine palladium(II) hydrogen carbonate425-270-0134620-00-1Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H410
   
047-001-00-2silver nitrate231-853-97761-88-8Ox. Sol. 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H272
H314
H400
H410
GHS03
GHS05
GHS09
Dgr
H272
H314
H410
   
047-002-00-8polyphosphoric acid, copper,
sodium, magnesium, calcium, silver
and zinc salt
416-850-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
047-003-00-3
Silber-Zink-Zeolith (Zeolith,
Linde Typ A, Oberfläche
mit Silber- und Zinkionen
modifiziert)
[Dieser Eintrag betrifft Zeolith
vom Typ LTA (Linde Typ A),
dessen Oberfläche mit Silber-
und Zinkionen mit einem Gehalt von Ag+ 0,5 %–6 %, Zn2+ 5 %–16 % und möglicherweise Phospor, NH4+, Mg2+ und/oder Ca2+ jeweils < 3 % modifiziert wurde.]
130328-20-0Repr. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H315
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H361d
H315
H318
H410
 M = 100
M = 100
 
048-001-00-5cadmium compounds, with the exception of
cadmium sulphoselenide (xCdS.yCdSe),
reaction mass of cadmium sulphide with
zinc sulphide (xCdS.yZnS), reaction mass of
cadmium sulphide with mercury sulphide
(xCdS.yHgS), and those specified elsewhere
in this Annex
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
 *A 1
048-002-00-0cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]
215-146-2 [2]
7440-43-9 [1]
1306-19-0 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361fd
H330
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361fd
H330
H372 **
H410
   
048-003-00-6cadmium diformate;
cadmiumformate
224-729-04464-23-7Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410
 *
STOT RE 2;
H373: C ≥ 0,25 %
 
048-004-00-1cadmium cyanide208-829-1542-83-6Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H351
H373 **
H410
EUH032STOT RE 2;
H373: C ≥ 0,1 %
EUH032: C ≥ 1 %
 
048-005-00-7cadmiumhexafluorosilicate(2-);
cadmium fluorosilica
241-084-017010-21-8Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410
 *
STOT RE 2;
H373: C ≥ 0,1 %
 
048-006-00-2cadmium fluoride232-222-07790-79-6Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410
 Carc. 1B; H350: C
≥ 0,01 %
* oral
STOT RE 1;
H372: C ≥ 7 %
STOT RE 2: 0,1 % ≤ C < 7%
 
048-007-00-8cadmium iodide232-223-67790-80-9Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410
 *
STOT RE 2;
H373: C ≥ 0,1 %
 
048-008-00-3cadmium chloride233-296-710108-64-2Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410
 Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1;
H372: C ≥ 7 %
STOT RE 2;
H373: 0,1 % ≤ C < 7%
 
048-009-00-9cadmium sulphate233-331-610124-36-4Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410
 Carc. 1B; H350: C
≥ 0,01 %
* oral
STOT RE 1;
H372: C ≥ 7 %
STOT RE 2;
H373: 0,1 % ≤ C < 7%
 
048-010-00-4cadmium sulphide215-147-81306-23-6Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4
H350
H341
H361fd
H372 **
H302
H413
GHS08
GHS07
Dgr
H350
H341
H361fd
H372 **
H302
H413
 *
STOT RE 1;
H372: C ≥ 10 %
STOT RE 2;
H373: 0,1 % ≤ C < 10 %
1
048-011-00-Xcadmium (pyrophoric)231-152-87440-43-9Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H250
H350
H341
H361fd
H330
H372 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H250
H350
H341
H361fd
H330
H372 **
H410
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
048-012-00-5
Cadmiumcarbonat208-168-9513-78-0Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H410
  A 1
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
048-013-00-0
Cadmiumhydroxid;
Cadmiumdihydroxid
244-168-521041-95-2Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H410
  A 1
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
048-014-00-6
Cadmiumnitrat; Cadmiumdinitrat233-710-610325-94-7Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372
(Nieren, Knochen)
H410
 Carc. 1B;
H350:
C ≥ 0,01 %
A 1
050-001-00-5tin tetrachloride;
stannic chloride
231-588-97646-78-8Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
 STOT SE 3;
H335: C ≥ 5 %
 
050-002-00-0cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide
236-049-113121-70-5Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
 M = 1000 
050-003-00-6fentin acetate (ISO);
triphenyltin acetate
212-984-0900-95-8Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H410
 M = 10 
050-004-00-1fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-676-87-9Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H410
 M = 10 
050-005-00-7trimethyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
 *A 1
050-006-00-2triethyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
 *A 1
050-007-00-8tripropyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
 *A 1
050-008-00-3Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführtRepr. 1B
Acute Tox. 3
Acute Tox. 4 *
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H301
H312
H372 **
H315
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H360FD
H301
H312
H372 **
H315
H319
H410
 *
STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,25 %
≤ C < 1 %
Skin Irrit. 2;
H315:
C ≥ 1 %
Eye Irrit. 2;
H319:
C ≥ 1 %
M = 10
A 1
050-009-00-9fluorotripentylstannane; [1]
hexapentyldistannoxane [2]
243-546-7 [1]
247-143-7 [2]
20153-49-5 [1]
25637-27-8 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
 *1
050-010-00-4fluorotrihexylstannane243-547-220153-50-8Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
 *1
050-011-00-Xtriphenyltin compounds, with the exception
of those specified elsewhere in this Annex
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
 *
M = 100
A 1
050-012-00-5tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3]
215-910-5 [1]
221-437-5 [2]
230-358-5 [3]
1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
 *A 1
050-013-00-0trioctyltin compounds, with the exception of
those specified elsewhere in this Annex
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4
H319
H335
H315
H413
GHS07
Wng
H319
H335
H315
H413
 Skin Irrit. 2;
H315: C ≥ 1 %
Eye Irrit. 2; H319:
C ≥ 1%
STOT SE 3;
H335: C ≥ 1 %
A 1
050-017-00-2fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-713356-08-6Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H319
H315
H400
H410
GHS06
GHS09
Dgr
H330
H319
H315
H410
   
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H411
   
050-019-00-3azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H–1,2,4-triazole
255-209-141083-11-8Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H301
H335
H315
H318
H410
   
050-020-00-9trioctylstannane413-320-4869-59-0STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4
H372 **
H315
H413
GHS08
GHS07
Dgr
H372 **
H315
H413
   
050-021-00-4dichlorodioctyl stannane222-583-23542-36-7Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H331
H372 **
H412
GHS06
GHS08
Dgr
H331
H372 **
H412
   
050-022-00-Xdibutyltin dichloride;
(DBTC)
211-670-0683-18-1Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H360FD
H330
H301
H312
H372 **
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H360FD
H330
H301
H312
H372 **
H314
H410
 Skin Corr. 1B; H314:
C ≥ 5 %
Skin Irrit. 2; H315:
0,01 % ≤ C < 5 %
Eye Dam. 1; H318:
3 % ≤ C < 5 %
Eye Irrit. 2; H319:
0,01 % ≤ C < 3 %
M = 10
 
050-023-00-5reaction mass of: bis[(2-ethyl-1-
oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohex­yl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedio­nyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-
phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
 M = 10 
050-024-00-0reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372 **
H302
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372 **
H302
H315
H318
H317
H410
   
050-025-00-6trichloromethylstannane213-608-8993-16-8Repr. 2H361dGHS08
Wng
H361d   
050-026-00-12-ethylhexyl 10-ethyl-4-[[2-
[(2-ethylhexyl)oxy]-2-oxo-
ethyl]thio]-4-methyl-7-oxo-8-
oxa-3,5-dithia-4-stanna-
tetradecanoate
260-828-557583-34-3Repr. 2H361dGHS08
Wng
H361d   
050-027-00-72-ethylhexyl 10-ethyl-4,4-
dioctyl-7-oxo-8-oxa-3,5-dithia-
4-stannatetradecanoate
239-622-415571-58-1Repr. 1BH360DGHS08
Dgr
H360D   
050-028-00-22-ethylhexyl 10-ethyl- 4,4-dimethyl-7-oxo-8- oxa-3,5-dithia-4-stannatetradecanoate260-829-057583-35-4Repr. 2
Acute Tox. 4
STOT RE 1
Skin Sens. 1A
H361d
H302
H372
(Nerven-
system, Immun-
system)
H317
GHS08
GHS07
Dgr
H361d
H302
H372
(Nerven-
system, Immun-
system)
H317
   
050-029-00-8dimethyltin dichloride212-039-2753-73-1Repr. 2
Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 1
Skin Corr. 1B
H361d
H330
H301
H311
H372 (Nerven-
system, Immun-
system)
H314
GHS08
GHS06
GHS05
Dgr
H361d
H330
H301
H311
H372 (Nerven-
system, Immun-
system)
H314
EUH071  
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
050-030-00-3
Dibutylzinndilaurat;
Dibutyl[bis(dodecanoyloxy)]-
stannan
201-039-877-58-7Muta. 2
Repr. 1B
STOT RE 1
H341
H360FD
H372
(Immun-
system)
GHS08
Dgr
H341
H360FD
H372
(Immun-
system)
   
051-001-00-8antimony trichloride233-047-210025-91-9Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
 STOT SE 3;
H335: C ≥ 5 %
 
051-002-00-3antimony pentachloride231-601-87647-18-9Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
 STOT SE 3;
H335: C ≥ 5 %
 
051-003-00-9antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5),
trisulphide (Sb2S3), pentasulphide (Sb2S5)
and those specified elsewhere in this Annex
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411
 *A 1